Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle

Mutation Research - DNA Repair

Volumn 459, Issue 2, 2000, Pages 123-133

  Pichierri, P ^a   Franchitto, A ^a   Mosesso, P ^a   Proietti De Santis, L ^a   Balajee, A S ^b   Palitti, F ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Chromosomal aberrations; Recombination and DNA repair; Topoisomerase II inhibitors; Werner's syndrome

Indexed keywords

AMSACRINE; DEMECOLCINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE;

ARTICLE; BASE MISPAIRING; CELL CYCLE G2 PHASE; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA REPAIR; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; WERNER SYNDROME;

AMSACRINE; CELL LINE, TRANSFORMED; DNA DAMAGE; DNA HELICASES; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; G2 PHASE; HUMANS; NUCLEIC ACID SYNTHESIS INHIBITORS; RECQ HELICASES; WERNER SYNDROME;

EID: 0034689364     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(99)00065-8     Document Type: Article

References (31)

1. Salk D., Au K., Hoehn H., Martin G.M. Cytogenetic aspects of Werner syndrome. Adv. Exp. Med. Biol. 190:1985;541-546.
2. Goto M., Tanimoto K., Horiuchi Y., Sasazuki T. Family analysis of Werner's syndrome: a survey of 42 Japanese families with a review of the literature. Clin. Genet. 19:1981;8-15.
3. Hrabko R.P., Milgrom H., Schwartz R.A. Werner's syndrome with associated malignant neoplasms. Arch. Dermatol. 118:1982;106-108.
4. Sato K., Goto M., Nishioka K., Arima K., Hori N., Yamashita N., Fujimoto Y., Nanko H., Ohara K., Ohara K. Werner's syndrome associated with malignancies: five case reports with a survey of case histories in Japan. Gerontology. 34:1988;212-218.
5. Faragher R.G., Kill I.R., Hunter J.A., Pope F.M., Tannock C., Shall S. The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc. Natl. Acad. Sci. U.S.A. 15:1993;12030-12034.
6. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J., Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science. 272:1996;258-262.
7. Gray M.D., Shen J., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., loeb L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17:1997;100-103.
8. Suzuki N., Shimamoto A., Imamura O., Kuromitsu J., Kitao S., Goto M., Furuichi Y. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res. 25:1997;2973-2978.
9. Gebhart E., Bauer R., Raub U., Schinzel M., Ruprecht K.W., Jonas J.B. Spontaneous and induced chromosomal instability in Werner syndrome. Hum. Genet. 80:1988;135-139.
10. Salk D., Au K., Hoehn H., Martin G.M. Cytogenetics of Werner syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet. Cell Genet. 30:1981;92-107.
11. Duguet M. When helicase and topoisomerase meet. J. Cell Sci. 110:1997;1345-1350.
12. Umezu K., Nakayama K., Nakayama H. Escherichia coli RecQ protein is a DNA helicase. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5363-5367.
13. Gangloff S., McDonald J.P., Bendixen C., Arthur L., Rothstein R. The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol. Cell. Biol. 14:1994;8391-8398.
14. Watt P.M., Luis E.J., Borts R.H., Hickson I.D. Sgs1: a eukaryotic homologue of E. coli RecQ that interact with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell. 81:1995;253-260.
15. Sinclair D.A., Guarente L. Extrachromosomal rDNA circles - a cause of aging in yeast. Cell. 91:1997;1033-1042.
16. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:1989;351-375.
17. Andersson H.C., Kihlman B.A. The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II: I. m-AMSA. Carcinogenesis. 10:1989;123-130.
18. Darroudi F., Natarajan A.T. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cell, xrs 5 and xrs 6: IV. Study of chromosomal aberrations and sister chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II. Mutat. Res. 212:1989;137-148.
19. Chatterjee S., Trivedi D., Petzold S.J., Berger N.A. Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines. Cancer Res. 50:1990;2713-2718.
20. Poot M., Hoehn H., Runger T.M., Martin G.M. Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp. Cell Res. 202:1992;267-273.
21. Perry P.E., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158.
22. Watt P.M., Hickson I.D., Borts R.H., Louis E.J. SGS1, a homologue of the Bloom's and Werner's syndrome genes, is required for maintenance of genome stability in Saccharomyces cerevisiae. Genetics. 144:1996;935-945.
23. Runger T.M., Bauer C., Dekant B., Moller K., Sobotta P., Czerny C., Poot M., Martin G.M. Hypermutable ligation of plasmid DNA ends in cells from patients with Werner syndrome. J. Invest. Dermatol. 102:1994;45-48.
24. Yamagata K., Kato J., Shimamoto A., Goto M., Furuichi Y., Ikeda H. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8733-8738.
25. Elli R., Chessa L., Antonelli A., Petrinelli P., Ambra R., Marcucci L. Effect of topoisomerase II inhibition in lymphoblasts from patients with Progeroid and "Chromosome Instability" syndromes. Cancer Genet. Cytogenet. 87:1996;112-116.
26. Okada M., Goto M., Furuichi Y., Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol. Pharm. Bull. 21:1998;235-239.
27. Poot M., Gollahon K.A., Rabinovitch P.S. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum. Genet. 104:1999;10-14.
28. Lebel M., Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13097-13102.
29. Ikushima T., Shima Y., Ishii Y. Effects of an inhibitor of topoisomerase II, ICRF-193 on the formation of ultraviolet-induced chromosomal aberrations. Mutat. Res. 404:1998;35-38.
30. Aratani Y., Andoh H., Koyama H. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells. Mutat. Res. 362:1996;181-191.
31. Franchitto A., Proietti De Santis L., Pichierri P., Mosesso P., Palitti F. Lack of effect of caffeine post-treatments on X-ray-induced aberrations yield in Werner's syndrome lymphoblastoid cell lines. Int. J. Radiat. Biol. 75:1999;1349-1355.